key: cord-0895267-lpebquti
authors: NM, Shruthi; Madaan, Priyanka; Shekhar, Mithun
title: An unusual descending presentation of pediatric Guillain-Barre syndrome following COVID-19: Expanding the spectrum
date: 2021-08-06
journal: Pediatr Neurol
DOI: 10.1016/j.pediatrneurol.2021.07.016
sha: ad8a77c8ae42c053e1019a13506ecc74114661b5
doc_id: 895267
cord_uid: lpebquti

nan

We read with great interest the article by Kaur et al (1) describing the aggressive clinical course in a child with COVID-19 associated transverse myelitis. We would like to share our experience in a child with COVID-19 associated Guillain Barre syndrome (GBS).

A developmentally normal 4-year-old girl, presented with a two-day history of pain in neck, neck floppiness, change in voice, drooling, and bilateral upper limb weakness. Two weeks before this illness, she had a mild febrile illness without any focus. There was no past history of confirmed COVID-19 or COVID-19 vaccination. Examination revealed facial diplegia, bulbar weakness, neck-flop, symmetric proximal-predominant flaccid quadriparesis (upper limb weakness>lower limb), respiratory muscle weakness (requiring mechanical ventilation), and generalized areflexia, without any ophthalmoplegia, encephalopathy, meningism, or other involvement. Inflammatory markers and SARS-CoV-2 PCR were negative. Serum IgG antibodies for SARS-CoV-2 were strongly positive. Nerve conduction study revealed markedly reduced amplitudes, abnormally prolonged distal latencies, and normal conduction velocities in motor nerves with normal sensory study. Cerebrospinal fluid (CSF; day3) showed mildly elevated protein (51mg/dl, normal: 15-40mg/dl) while CSF viral panel was negative. Spine magnetic resonance imaging revealed contrast enhancement of the lumbosacral nerve roots (D12 to S1) while brain imaging was normal (Fig 1) . Considering COVID-19 associated GBS (postinfectious), she was managed with Intravenous immunoglobulin (2g/kg over 5days). She responded well and was discharged by day10 (off ventilator, walking with support at discharge).

This report adds to the evolving spectrum of neurological presentations of COVID-19 in children. The literature on COVID-19 associated GBS in children is scarce with most cases being either demyelinating or motor axonal variants. Although establishing causality with COVID-19 J o u r n a l P r e -p r o o f is often difficult, the importance of COVID-19 antibody (IgM and IgG) testing in GBS cannot be understated (when SARS-CoV-2 PCR is negative) especially during the pandemic (2) .

Descending involvement, as in the index child, is extremely rare in children and has not been described with COVID-19 (3, 4) . Hence, this report highlights the importance of being familiar with the wide-ranging heterogenous and atypical presentations of COVID-19. 

Transverse Myelitis in a Child With COVID-19

Neurological Manifestations of COVID-19 in Children: Time to Be More Vigilant

Atypical Findings of Guillain-Barré Syndrome in Children

The pharyngeal-cervical-brachial form of Guillain-Barré syndrome in childhood